The historical rank and industry rank for Fisher & Paykel Healthcare's PB Ratio or its related term are showing as below:
FRA:FPLB'
s PB Ratio Range Over the Past 10 Years
Min: 6.33 Med: 10.81 Max: 22.23
Current: 10.26
During the past 13 years, Fisher & Paykel Healthcare's highest PB Ratio was 22.23. The lowest was 6.33. And the median was 10.81.
FRA:FPLB's PB Ratio is ranked worse than 91.62% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.045
vs FRA:FPLB: 10.26
During the past 12 months, Fisher & Paykel Healthcare's average Book Value Per Share Growth Rate was 11.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 6.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 5.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 14.60% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Fisher & Paykel Healthcare was 25.60% per year. The lowest was 0.00% per year. And the median was 8.80% per year.
Back to Basics: PB Ratio
Fisher & Paykel Healthcare (FRA:FPLB) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Fisher & Paykel Healthcare PB Ratio Related Terms
Fisher & Paykel Healthcare PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fisher & Paykel Healthcare PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's PB Ratio distribution charts can be found below:
* The bar in red indicates where Fisher & Paykel Healthcare's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Fisher & Paykel Healthcare (FRA:FPLB) has a PB Ratio of 10.37 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Fisher & Paykel Healthcare and its competitors. This is near median its historical median of 10.81. Over the past decade, Fisher & Paykel Healthcare's PB Ratio has ranged from 6.33 to 22.23. According to the industry distribution chart, Fisher & Paykel Healthcare ranks #722 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 91.6%.
Is Fisher & Paykel Healthcare's PB Ratio too high?
Fisher & Paykel Healthcare's current PB Ratio of 10.37 is near median its 10-year median of 10.81. Over the past 10 years, this metric has ranged from a low of 6.33 to a high of 22.23. The Medical Devices & Instruments industry median PB Ratio is 2.05. Fisher & Paykel Healthcare's value of 10.37 is 407.1% above this industry median. Based on the distribution chart, Fisher & Paykel Healthcare ranks #722 out of 788 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Fisher & Paykel Healthcare has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Fisher & Paykel Healthcare's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fisher & Paykel Healthcare ranks #722 out of 788 companies for PB Ratio. This places Fisher & Paykel Healthcare in the lower half of its industry. The industry median PB Ratio is 2.05. Fisher & Paykel Healthcare's value of 10.37 is 407.1% above this benchmark. Historically, Fisher & Paykel Healthcare's own PB Ratio has ranged from 6.33 to 22.23 over the past decade. While the company's 10-year median is 10.81 vs. the industry median of 2.05, Fisher & Paykel Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fisher & Paykel Healthcare's current PB Ratio of 10.37 is 407.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Fisher & Paykel Healthcare and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fisher & Paykel Healthcare's current PB Ratio is 10.37, which is near median its own 10-year median of 10.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fisher & Paykel Healthcare stock overvalued right now?
Fisher & Paykel Healthcare (FRA:FPLB) has a current PB Ratio of 10.37. The stock's GF Value™ is €21.23, compared to a current price of €18.90 — trading 11% below its estimated fair value. The current PB Ratio is 10.37, which is near median its 10-year median of 10.81 and 407.1% above the Medical Devices & Instruments industry median of 2.05. Fisher & Paykel Healthcare's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Fisher & Paykel Healthcare (FRA:FPLB), the current PB Ratio is 10.37 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fisher & Paykel Healthcare (FRA:FPLB) Overvalued in 2026?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare stock appears to be undervalued.
The current stock price of €18.90 is trading 11% below its estimated GF Value™ of €21.23.
Key valuation signals for FRA:FPLB:
PB Ratio: 10.37 (near median its 10-year median of 10.81)
GF Value™: €21.23 vs. price of €18.90 (11% below fair value)
Industry Position: 407.1% above the Medical Devices & Instruments median (#722 of 788)
No single metric tells the full story. See the FRA:FPLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
91GF Score
Get the complete analysis for FRA:FPLB
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:FPLB has been successfully added to your 
